Evidence map›Paper›PMID 31484701›Full record

ArticleJournal of clinical microbiology2019

Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program.

K B Waites, A Ratliff, D M Crabb, L Xiao, X Qin, R Selvarangan, Y-W Tang, X Zheng, J Dien Bard, T Hong and 7 more

Open access · bronzeAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 2 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 2 syntheses or guidelines pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Therapeutic efficacy of pharmacist-integrated clinic in evidence-based treatment for pediatric mycoplasma pneumoniae pneumonia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Trial
  4. Reporting macrolide-resistantJournal of clinical microbiology · 2026
    Review
  5. Serum Interferon-γ Is Associated With RefractoryJournal of Korean medical science · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. A bibliometric analysis of the literature onSouthern African journal of infectious diseases · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 1 country.

K B WaitesDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA kwaites@uabmc.edu.
A RatliffDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
D M CrabbDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
L XiaoDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
X QinDepartment of Laboratory Medicine and Pathology, Seattle Children's Hospital, Seattle, Washington, USA.
R SelvaranganChildren's Mercy Hospital, Kansas City, Missouri, USA.
Y-W TangMemorial Sloan Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York, USA.ORCID 0000-0003-4888-6771
X ZhengAnn and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.ORCID 0000-0003-4897-9943
J Dien BardDepartment of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
T HongDepartment of Pathology, Hackensack University Medical Center, Hackensack, New Jersey, USA.
M PrichardDepartment of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
E BrooksDepartment of Pediatrics, University of Texas Health Science Center, San Antonio, Texas, USA.
S DallasDepartment of Pathology, University of Texas Health Science Center, San Antonio, Texas, USA.
L DuffyDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
E MixonDepartment of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
K B FowlerDepartment of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
T P AtkinsonDepartment of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
University of Alabama at Birmingham · USThe University of Texas Health Science Center at San Antonio · USChildren's Mercy Hospital · USHackensack University Medical Center · USLurie Children's Hospital · USMemorial Sloan Kettering Cancer Center · USSeattle Children's Hospital · USUniversity of Southern California · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
CDC HHS 200-2017-96217NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

There are sparse data to indicate the extent that macrolide-resistant

Indexed as

AdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsChildChild, PreschoolDrug Resistance, BacterialEpidemiological MonitoringFemaleHumansInfantMacrolidesMaleMicrobial Sensitivity TestsMiddle AgedAnti-Bacterial AgentsMacrolidesRNA, Ribosomal, 23Santibiotic resistancemacrolideMycoplasma pneumoniaesurveillance

Identifiers

PMID31484701
PMCPMC6813023
OpenAlexW2970956159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.